Close Menu

Virginia Commonwealth University

The National Institutes of Health also said that it has added four additional healthcare provider organizations to help advance the initiative.

AlloSure 3.0 can diagnose the very early stages of T-cell mediated rejection, allowing clinicians to begin anti-rejection therapies and monitor treatment.

The studies, which used multi-omic approaches, are part of the integrative Human Microbiome Project (iHMP) — the second phase of the Human Microbiome Project.

NEW YORK (GenomeWeb) – A research team at Virginia Commonwealth University has received a $6.9 million grant from the National Institute on Alcohol Abuse and Alcoholism to expand its research program examining the molecular and genetic causes of alcohol abuse and alcoholism.

NEW YORK (GenomeWeb) – Researchers at Virginia Commonwealth University have reeled in a $3 million grant from the National Institute of Mental Health to investigate whether adverse experiences during childhood leave molecular marks that potentially could be used in diagnostic tests to predict hea

NEW YORK (GenomeWeb) — Researchers from Virginia Commonwealth University have developed a method of quantifying multiple nucleic acid targets in a single sample by combining low-cycle-number, target-specific PCR with atomic force microscopy.

A study appearing online in JAMA Psychiatry suggests methylation marks in and around dozens of genes may serve as biomarkers for schizophrenia, providing potential clue

Researchers from Virginia Commonwealth University are planning a study of DNA methylation, with the hope that it will yield a molecular signature that can be used to personalize treatment for depression by distinguishing those who are likely to have a chronic form of the disease

Protea, VCU Collaborating to Improve Molecular Imaging For Various Diseases

NEW YORK (GenomeWeb News) – Protea Biosciences said today that it has entered into a collaborative research agreement with Virginia Commonwealth University and its Center for Molecular Imaging focused on improved molecular imaging techniques for the study of cancer, Alzheimer's, and other disease

Pages

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.